Silver Spring, Maryland–(ENEWSPF)–April 15, 2014. The U.S. Food and Drug Administration today approved Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
FDA Approves Tanzeum to Treat Type 2 Diabetes
More in Health and Fitness:
